Response Genetics (RGDX) in Focus: Stock Up 18.3% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Response Genetics, Inc ( RGDX ) was a big mover last session, as its shares rose over 18% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since March 19, as the stock is now down over 4%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Response Genetics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. ( ANIP ), Alkermes plc ( ALKS ) and Alexion Pharmaceuticals, Inc. ( ALXN ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

ALKERMES INC (ALKS): Free Stock Analysis Report

ALEXION PHARMA (ALXN): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

RESPONSE GENETC (RGDX): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ALKS , ALXN , ANIP , RGDX

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by